Approved for Maintenance treatment of asthma in patients aged 12 years and older. Combines mometasone furoate (inhaled corticosteroid) and formoterol fumarate (long-acting beta-2 agonist). Provides both anti-inflammatory and bronchodilator effects in a single inhaler. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC…
Loading full data from Know Your Drugs Institute…